Stay updated on CDX-1401+INCB024360 in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the CDX-1401+INCB024360 in Ovarian Cancer Clinical Trial page.

Latest updates to the CDX-1401+INCB024360 in Ovarian Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedPrimary peritoneal carcinoma was added to the study conditions, and a Genetic and Rare Diseases Information Center resource link was added. The page footer was updated to Revision 3.4.2 and the funding-status notice was removed.SummaryDifference0.6%

- Check21 days agoChange DetectedA government funding lapse notice was added to the page and the site revision tag was updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check28 days agoChange DetectedAdded a Show glossary option and updated footer/version text (Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0); removed the older labels Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page shows a minor revision update from v3.3.3 to v3.3.4 with no substantive changes to the study content or data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded a Locations section with New York listed as a study location; removed the separate 'New York Locations' heading and the 'HHS Vulnerability Disclosure' link.SummaryDifference0.2%

- Check91 days agoChange DetectedThe update appears to be a minor revision tag change from v3.2.0 to v3.3.2 with no visible changes to study content or layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to CDX-1401+INCB024360 in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CDX-1401+INCB024360 in Ovarian Cancer Clinical Trial page.